On the safety of intravenous iron, evidence trumps conjecture
暂无分享,去创建一个
J. Adamson | I. Macdougall | F. Locatelli | D. Rampton | G. Rodgers | A. Bircher | C. Gasche | G. Liumbruno | G. Grazzini | A. Gafter-Gvili | A. Shander | M. Muñoz | D. Henry | S. Fishbane | C. Breymann | M. Auerbach | J. Gilreath
[1] A. Bircher,et al. Hypersensitivity from intravenous iron products. , 2014, Immunology and allergy clinics of North America.
[2] I. Macdougall,et al. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[3] Seth R Flaxman,et al. A systematic analysis of global anemia burden from 1990 to 2010. , 2014, Blood.
[4] I. Hussain,et al. Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia , 2013, Anemia.
[5] N. Hevelone,et al. Comparative rates of adverse events with different formulations of intravenous iron , 2012, American journal of hematology.
[6] B. Myers,et al. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy , 2012, Obstetric medicine.
[7] N. Dahl,et al. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia , 2011, American journal of hematology.
[8] Catherine M. Dormitzer,et al. Use of parenteral iron products and serious anaphylactic‐type reactions , 2010, American journal of hematology.
[9] D. Cella,et al. High-molecular weight iron dextran: a wolf in sheep's clothing? , 2008, Journal of the American Society of Nephrology : JASN.
[10] J. Critchley,et al. Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review , 2007 .
[11] G. Chertow,et al. Update on adverse drug events associated with parenteral iron. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] E. Barton,et al. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. , 2000, The American journal of medicine.
[13] S. Fishbane,et al. The safety of intravenous iron dextran in hemodialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] L. Leibovici,et al. The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.